LIMITED HUMAN LYME IGG WESTERN BLOT KIT (CAMBRIDGE DIAGNOSTICS IRELAND)— 510(k) K970761

Name: FDA 510(k) clearance K970761
Creator: U.S. Food and Drug Administration
Published: 1998-04-09

Substantially Equivalent

Cambridge Diagnostics Ireland, Ltd.

FDA 510(k) clearance K970761 for LIMITED HUMAN LYME IGG WESTERN BLOT KIT (CAMBRIDGE DIAGNOSTICS IRELAND), Substantially Equivalent on 1998-04-09. Applicant: Cambridge Diagnostics Ireland, Ltd.. Device class: 2.

Clearance details

Applicant: Cambridge Diagnostics Ireland, Ltd.
Product code: Code LSR
Device class: Class 2
Regulation: 21 CFR 866.3830
Advisory panel: Microbiology
Date received: 1997-03-03
Decision date: 1998-04-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Galway, IE

Download summary PDF View on FDA.gov ↗

Recent devices under product code LSR

view all

K254295 — Sofia Lyme FIA; Sofia 2 Campylobacter FIA2026-07-10
K252627 — Lyme-ID IgG Test; Bio-ID8002025-11-14
K242872 — iDart Lyme IgM ImmunoBlot Kit2025-06-12
K233367 — iDart Lyme IgG ImmunoBlot Kit2024-08-12
K230863 — ZEUS Solinas Borrelia VlsE1/pepC10 IgG/IgM Test System; ZEUS Solinas Borrelia VlsE1/pepC10 IgG/IgM Control Kit2023-07-13

More clearances from Cambridge Diagnostics Ireland, Ltd.

view all

K013907 — INVERNESS MEDICAL EARLY PREGNANCY TEST2001-12-18
K970768 — HUMAN LYME IGM WESTERN BLOT KIT1998-04-09
K955903 — SELFCARE EARLY PREGNANCY TEST1996-03-06

Data sourced from openFDA. This site is unofficial and independent of the FDA.